Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : YEEHAW CANDIDATES -- Ignore unavailable to you. Want to Upgrade?

To: J.F. who wrote (22558)	2/7/2007 5:30:31 PM
From: J.F.	Respond to of 23958

Memory Pharmaceuticals to Present at Bio CEO & Investor Conference 2007Last update: 2/7/2007 5:14:00 PMMONTVALE, N.J., Feb 07, 2007 /PRNewswire-FirstCall via COMTEX/ -- Memory Pharmaceuticals Corp. (MEMY) today announced that Jim Sulat, President and Chief Executive Officer, will provide a Company update at the Bio CEO & Investor Conference 2007 on Wednesday, February 14, 2007 at 12:45 p.m. ET, at the Waldorf=Astoria, New York City. Interested parties may access a live audio webcast of the presentation by visiting the Investor Relations section of Memory Pharmaceuticals' website at . An archived version of the webcast will be available at the same location through Wednesday, February 21, 2007. About the Company Memory Pharmaceuticals Corp., a biopharmaceutical company, is focused on developing innovative drugs for the treatment of debilitating CNS disorders such as Alzheimer's disease, schizophrenia, depression and bipolar disorder. For additional information, please visit our website at . SOURCE Memory Pharmaceuticals Corp. Jzaneen Lalani, General Counsel, +1-201-802-7140; or Lilian Stern, Stern InvestorRelations, Inc., +1-212-362-1200